Suchergebnisse - "Stagno, Fabio"

PubPharm (6)

1

Diagnosis of blastic phase of chronic myeloid leukemia

enthalten in: Acta haematologica | 2012

von Stagno, F. | Vigneri, P. | Cupri, A. | +2

CommentOn: Acta Haematol. 2012;127(3):143-8. - PMID 22248505

2

Imatinib discontinuation : realistic for patients with chronic myeloid leukaemia achieving complete molecular remission?

enthalten in: The Lancet. Oncology | 2011

von Stagno, F. | Vigneri, P. | Di Raimondo, F.

CommentOn: Lancet Oncol. 2010 Nov;11(11):1029-35. - PMID 20965785

3

Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy

enthalten in: Leukemia research | 2010

von Breccia, M. | Santopietro, M. | Loglisci, G. | +4

4

Imatinib dose escalation in 74 failure or suboptimal response chronic myeloid leukaemia patients at 3-year follow-up

enthalten in: American journal of hematology | 2010

von Breccia, M. | Stagno, F. | Vigneri, P. | +5

5

Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis

enthalten in: Leukemia research | 2008

von Stagno, F. | Stella, S. | Berretta, S. | +6

6

Successful treatment of advanced idiopathic myelofibrosis with imatinib mesylate

enthalten in: European journal of haematology | 2004

von Stagno, F. | Consoli, C. | Mannino, F. | +2

1
[1]